Literature DB >> 27246541

Strict glucose control and artificial regulation of the NO-ADMA-DDAH system in order to prevent endothelial dysfunction.

Saskia J H Brinkmann1, E A Wörner1, Paul A M van Leeuwen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27246541      PMCID： PMC4887691          DOI： 10.1113/JP272183

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  11 in total

Review 1.  The clinical significance of asymmetric dimethylarginine.

Authors:  Michiel P C Siroen; Tom Teerlink; Robert J Nijveldt; Hubert A Prins; Milan C Richir; Paul A M van Leeuwen
Journal:  Annu Rev Nutr       Date:  2006       Impact factor: 11.848

2.  Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model.

Authors:  Tsuneo Kobayashi; Kumiko Taguchi; Takenouchi Yasuhiro; Takayuki Matsumoto; Katsuo Kamata
Journal:  Hypertension       Date:  2004-10-25       Impact factor: 10.190

Review 3.  Asymmetric dimethylarginine and critical illness.

Authors:  Saskia J H Brinkmann; Myrte C de Boer; Nikki Buijs; Paul A M van Leeuwen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-01       Impact factor: 4.294

4.  Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?

Authors:  Michiel P C Siroen; Paul A M van Leeuwen; Robert J Nijveldt; Tom Teerlink; Pieter J Wouters; Greet Van den Berghe
Journal:  Crit Care Med       Date:  2005-03       Impact factor: 7.598

5.  Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling.

Authors:  Rong Li; Haifeng Zhang; Wenqing Wang; Xiaoming Wang; Yuxiao Huang; Chen Huang; Feng Gao
Journal:  Eur J Pharmacol       Date:  2009-11-27       Impact factor: 4.432

6.  Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.

Authors:  Ken Y Lin; Akira Ito; Tomoko Asagami; Philip S Tsao; Shanthi Adimoolam; Masumi Kimoto; Hideaki Tsuji; Gerald M Reaven; John P Cooke
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

7.  Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.

Authors:  Mariam El Assar; Javier Angulo; Marta Santos-Ruiz; Juan Carlos Ruiz de Adana; María Luz Pindado; Alberto Sánchez-Ferrer; Alberto Hernández; Leocadio Rodríguez-Mañas
Journal:  J Physiol       Date:  2016-03-04       Impact factor: 5.182

8.  Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex.

Authors:  Quan-Jiang Zhang; William L Holland; Lloyd Wilson; Jason M Tanner; Devin Kearns; Judd M Cahoon; Dix Pettey; Jason Losee; Bradlee Duncan; Derrick Gale; Christopher A Kowalski; Nicholas Deeter; Alexandrea Nichols; Michole Deesing; Colton Arrant; Ting Ruan; Christoph Boehme; Dane R McCamey; Janvida Rou; Kapil Ambal; Krishna K Narra; Scott A Summers; E Dale Abel; J David Symons
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

9.  Preserved endothelial function in human obesity in the absence of insulin resistance.

Authors:  Mariam El Assar; Juan Carlos Ruiz de Adana; Javier Angulo; María Luz Pindado Martínez; Alberto Hernández Matías; Leocadio Rodríguez-Mañas
Journal:  J Transl Med       Date:  2013-10-20       Impact factor: 5.531

Review 10.  Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers.

Authors:  Li Lai; Yohannes T Ghebremariam
Journal:  J Diabetes Res       Date:  2015-12-06       Impact factor: 4.011
View more
  1 in total

1.  Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway.

Authors:  Isaivani Jayachandran; Saravanakumar Sundararajan; Saravanakumar Venkatesan; Sairaj Paadukaana; Muthuswamy Balasubramanyam; Viswanathan Mohan; Nagaraj Manickam
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.